Cost-effectiveness of endovascular revascularization compared to supervised hospital-based exercise training in patients with intermittent claudication: A randomized controlled trial

Journal of Vascular Surgery

Volumn 48, Issue 6, 2008, Pages 1472-1480

  Spronk, Sandra ^a,b   Bosch, Johanna L ^a   den Hoed, Pieter T ^b   Veen, Hermanus F ^b   Pattynama, Peter M T ^a   Hunink, M G Myriam ^a,c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b IKAZIA HOSPITAL   (Netherlands)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EXERCISE; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION;

AGED; COST-BENEFIT ANALYSIS; EXERCISE THERAPY; FEMALE; FOLLOW-UP STUDIES; HOSPITAL COSTS; HUMANS; INTERMITTENT CLAUDICATION; MALE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 56149114798     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2008.06.016     Document Type: Article

References (31)

1. Dormandy J., Mahir M., Ascady G., Balsano F., De Leeuw P., Blombery P., et al. Fate of the patient with chronic leg ischaemia. A review article. J Cardiovasc Surg (Torino) 30 (1989) 50-57
2. Balkau B., Vray M., and Eschwege E. Epidemiology of peripheral arterial disease. J Cardiovasc Pharmacol 23 Suppl 3 (1994) S8-S16
3. Rose G., McGartner P., and Reid D.D. Self-administration of a questionnaire on chest pain and intermittent claudication. Brit J Prevent Soc Med 31 (1977) 42-48
4. Isner J.M., and Rosenfield K. Redefining the treatment of peripheral artery disease. Role of percutaneous revascularization. Circulation 88 4 Pt 1 (1993) 1534-1557 Oct
5. Registration T. http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=199 Accessed 2006
6. Moher D., Pham B., Klassen T.P., Schulz K.F., Berlin J.A., Jadad A.R., and Liberati A. What contributions do languages other than English make on the results of meta-analyses?. J Clin Epidemiol 53 (2000) 964-972
7. NYHA c. Accessed 2006.
8. Dormandy J.A., and Rutherford R.B. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Concensus (TASC). J Vasc Surg 31 1 Pt 2 (2000) S1-S296
9. Wind J., and Koelemay M.J. Exercise therapy and the additional effect of supervision on exercise therapy in patients with intermittent claudication. Systematic review of randomised controlled trials. Eur J Vasc Endovasc Surg 34 (2007) 1-9
10. Oostenbrink J., Koopmanschap M., and Rutten F. Standardisation of costs: the Dutch manual for costing in economic evaluations. Pharmacoeconomics 20 (2002) 443-454
11. Dolan P. Modeling valuations for EuroQol health states. Med Care 35 (1997) 1095-1108
12. Busschbach J. http://www.xs4all.nl/∼jannetvb/busschbach/faq_qoL&euroqol.htm Accessed 2006.
13. Froberg D.G., and Kane R.L. Methodology for measuring health-state preferences-II: scaling methods. J Clin Epidemiol 42 (1989) 459-471
14. Ware Jr. J.E., and Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30 (1992) 473-483
15. Bosch J.L., van der Graaf Y., and Hunink M.G. Health-related quality of life after angioplasty and stent placement in patients with iliac artery occlusive disease: results of a randomized controlled clinical trial. The Dutch Iliac Stent Trial Study Group. Circulation 99 (1999) 3155-3160
16. Gold M. Panel on cost-effectiveness in health and medicine. Med Care 34 12 Suppl (1996) DS197-DS199
17. Eurostata. http://epp.eurostat.ec.europa.eu/portal/page?_pageid=1996,39140985&_dad=portal&_schema=PORTAL&screen=detailref&language=en&product=EU_shorties&root=EU_shorties/shorties/euro_cp/cp000 Updated daily. Accessed November 6, 2006
18. Central Bureau of Statistics The Netherlands. http://www.cbs.nl/ Accessed 2006
19. Spronk S., Bosch J.L., Veen H.F., den Hoed P.T., and Hunink M.G. Intermittent claudication: functional capacity and quality of life after exercise training or percutaneous transluminal angioplasty--systematic review. Radiology 235 (2005) 833-842
20. Mehta T., Venkata Subramaniam A., Chetter I., and McCollum P. Assessing the validity and responsiveness of disease-specific quality of life instruments in intermittent claudication. Eur J Vasc Endovasc Surg 31 (2006) 46-52
21. Bosch J.L., and Hunink M.G. The relationship between descriptive and valuational quality-of-life measures in patients with intermittent claudication. Med Decis Making 16 (1996) 217-225
22. van der Heijden G.J., Donders A.R., Stijnen T., and Moons K.G. Imputation of missing values is superior to complete case analysis and the missing-indicator method in multivariable diagnostic research: a clinical example. J Clin Epidemiol 59 (2006) 1102-1109
23. Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., and Fowkes F.G. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 45 1 Suppl (2007) S5-S67
24. Barber J.A., and Thompson S.G. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med 19 (2000) 3219-3236
25. Stinnett A.A., and Mullahy J. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making 18 2 Suppl (1998) S68-S80
26. Claxton K., Sculpher M., and Drummond M. A rational framework for decision making by the National Institute For Clinical Excellence (NICE). Lancet 360 (2002) 711-715
27. Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ 18 (1999) 341-364
28. Meijer W.T., Cost B., Bernsen R.M., and Hoes A.W. Incidence and management of intermittent claudication in primary care in The Netherlands. Scand J Prim Health Care 20 (2002) 33-34
29. de Vries S.O., Visser K., de Vries J.A., Wong J.B., Donaldson M.C., and Hunink M.G. Intermittent claudication: cost-effectiveness of revascularization versus exercise therapy. Radiology 222 (2002) 25-36
30. Adam D.J., Beard J.D., Cleveland T., Bell J., Bradbury A.W., Forbes J.F., et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 366 (2005) 1925-1934
31. Nylaende M., Abdelnoor M., Stranden E., Morken B., Sandbaek G., Risum Ø., et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT)-the 2-years results of a single centre, prospective, randomised study in patients with intermittent claudication. Eur J Vasc Endovasc Surg 33 (2007) 3-12